Category: Joint ventures/collaborations
-
Group Advancing Electronic Spinal Cord Injury Therapies
A consortium of academic and industry labs is integrating electronic sensors and neural stimulation therapies into an early treatment protocol for spinal cord injuries.
-
Study Testing Wearables Data for Covid-19 Clues
A biomedical engineering lab and analytics company are testing the feasibility of algorithms to find early signs of Covid-19 symptoms from smart watch users.
-
Dexcom, UVirginia Partner on Diabetes Technology
Dexcom Inc., a maker of glucose monitoring systems, and University of Virginia are collaborating on extending the company’s current technologies to cover more types of diabetes
-
Univ Lab, Company Developing Phone-Based Virus Sensor
A biotechnology company is sponsoring university research on light waves reacting in characteristic patterns for detecting SARS-CoV-2 viruses by a smartphone camera.
-
Biotechs Partner on Gene-Editing Cystic Fibrosis Therapy
Two biotechnology companies are adding to their current collaboration to develop delivery techniques for gene-editing treatments for cystic fibrosis.
-
NIH Trials Testing Covid-19 Blood Clot Therapies
National Institutes of Health is starting two clinical trials testing a number of blood thinning treatments for people with blood clots from Covid-19 infections.
-
Antibody Discovery Company Forms, Partners on Covid-19
A new enterprise formed to discover human therapeutic antibodies is partnering with a synthetic biology company to discover Covid-19 antibody treatments.
-
Sanofi, GSK Begin U.S. Covid-19 Vaccine Trial
Global drug makers Sanofi and GlaxoSmithKline are starting a clinical trial testing a vaccine to prevent Covid-19 infections among healthy adults in the U.S.
-
Biotechs, Univ. Labs Partner on Covid-19 Combo Therapy
Two biotechnology companies are developing a Covid-19 treatment that combines engineered antibodies and natural killer immune system cells.
-
Small Biz Grant Advances Neuro Protection Drugs
An NIH award to a biotechnology company funds discovery of drugs that protect brain cells from degenerative disorders like Alzheimer’s disease.